Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
Cencora, Inc. (COR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
01:10pm, Wednesday, 13'th May 2026
Cencora, Inc. (COR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Why Cencora (COR) is a Top Growth Stock for the Long-Term
10:46am, Tuesday, 12'th May 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cencora, Inc. (“C
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
10:40am, Monday, 11'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cencora, Inc. (COR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
09:00am, Monday, 11'th May 2026
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Cencora, Inc. (“Cencora” or the “Company”) (NYSE: COR) investors concerning the Compan
Cencora Q2 Earnings Call Highlights
05:05pm, Saturday, 09'th May 2026
Cencora NYSE: COR reported higher fiscal second-quarter adjusted earnings and operating income, while management raised its full-year adjusted EPS outlook and said it would resume opportunistic share
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Cencora, Inc. (“Cencora” or the “Company”) (NYSE: COR) on behalf of investors concerning the Compan
Cencora Earnings Review: The Selloff Was Overdone In My View
01:36pm, Thursday, 07'th May 2026
Cencora reported Q2 results with 3.8% revenue growth and a 129% EPS increase, but shares fell sharply, apparently due to a revenue miss. Despite a forward P/E of ~14 and manageable debt, COR faces thi
Cencora, Inc. (COR) Q2 2026 Earnings Call Transcript
05:01pm, Wednesday, 06'th May 2026
Cencora, Inc. (COR) Q2 2026 Earnings Call Transcript
Why Is Cencora Stock Trading Lower On Wednesday?
02:49pm, Wednesday, 06'th May 2026
Shares of Cencora Inc. (NASDAQ:COR) are trading lower on Wednesday as the company reported its fiscal 2026 second-quarter results and lowered its annual guidance.
COR Stock Falls on Q2 Earnings & Revenue Miss, FY26 EPS View Raised
01:01pm, Wednesday, 06'th May 2026
Cencora shares sink after Q2 earnings and revenues miss estimates, even as the company raises its fiscal 2026 EPS outlook.
Cencora (COR) Misses Q2 Earnings and Revenue Estimates
08:45am, Wednesday, 06'th May 2026
Cencora (COR) came out with quarterly earnings of $4.75 per share, missing the Zacks Consensus Estimate of $4.8 per share. This compares to earnings of $4.42 per share a year ago.
Cencora raises annual profit forecast despite quarterly miss
07:41am, Wednesday, 06'th May 2026
Cencora reported second-quarter results below Wall Street estimates on Wednesday but raised its annual profit forecast, betting on a steady demand for specialty medicines.
Cencora Reports Fiscal 2026 Second Quarter Results
06:30am, Wednesday, 06'th May 2026
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2026 second quarter ended March 31, 2026, revenue increased 3.8 percent year-over-year to $78.4 billion.
Cencora to Report Q2 Earnings: What's in Store for the Stock?
11:35am, Tuesday, 05'th May 2026
COR heads into Q2 earnings with expected steady specialty-driven growth, but customer losses and pricing pressures could temper results.
